Search research articles
Contact Us
Filters
Showing results (11-20 of 30) with videos related to
Page
of 3
Sort By:
Biochemical and Biophysical Research Communications
|
December 1, 2006
Heterodimerization of the alpha and beta isoforms of the human thromboxane receptor enhances isoprostane signaling
Stephen J Wilson, Kevin McGinley, Albert J Huang, et al.
Journal of Lipid Research
|
March 16, 2013
Biased suppression of TP homodimerization and signaling through disruption of a TM GxxxGxxxL helical interaction motif
Alexander J Frey, Salam Ibrahim, Scott Gleim, et al.
Molecular Pharmacology
|
January 19, 2006
The G12 family of G proteins as a reporter of thromboxane A2 receptor activity
Li Zhang, Cherisse DiLizio, David Kim, et al.
Journal of Lipid Research
|
December 20, 2008
Prostanoids in health and disease
Emer M Smyth, Tilo Grosser, Miao Wang, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
November 18, 2006
Regulation of thromboxane receptor trafficking through the prostacyclin receptor in vascular smooth muscle cells: role of receptor heterodimerization
Stephen J Wilson, Jennifer K Dowling, Lei Zhao, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
December 4, 2012
Endothelial 12(S)-HETE vasorelaxation is mediated by thromboxane receptor inhibition in mouse mesenteric arteries
Lawan Siangjong, Kathryn M Gauthier, Sandra L Pfister, et al.
Molecular Pharmacology
|
July 19, 2003
Prostacylin receptor activation inhibits proliferation of aortic smooth muscle cells by regulating cAMP response element-binding protein- and pocket protein-dependent cyclin a gene expression
Devashish Kothapalli, Sheryl A Stewart, Emer M Smyth, et al.
Breast Cancer Research : BCR
|
September 6, 2013
Mammary carcinoma cell derived cyclooxygenase 2 suppresses tumor immune surveillance by enhancing intratumoral immune checkpoint activity
Nune Markosyan, Edward P Chen, Rebecca A Evans, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
June 5, 2010
Dominant negative actions of human prostacyclin receptor variant through dimerization: implications for cardiovascular disease
Salam Ibrahim, Mazell Tetruashvily, Alex J Frey, et al.
Journal of Lipid Research
|
January 20, 2009
Activation-dependent stabilization of the human thromboxane receptor: role of reactive oxygen species
Stephen J Wilson, Claire C Cavanagh, Allison M Lesher, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 30) with videos related to
Sort By:
Page
of 3
Biochemical and Biophysical Research Communications
|
December 1, 2006
Heterodimerization of the alpha and beta isoforms of the human thromboxane receptor enhances isoprostane signaling
Stephen J Wilson, Kevin McGinley, Albert J Huang, et al.
Journal of Lipid Research
|
March 16, 2013
Biased suppression of TP homodimerization and signaling through disruption of a TM GxxxGxxxL helical interaction motif
Alexander J Frey, Salam Ibrahim, Scott Gleim, et al.
Molecular Pharmacology
|
January 19, 2006
The G12 family of G proteins as a reporter of thromboxane A2 receptor activity
Li Zhang, Cherisse DiLizio, David Kim, et al.
Journal of Lipid Research
|
December 20, 2008
Prostanoids in health and disease
Emer M Smyth, Tilo Grosser, Miao Wang, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
November 18, 2006
Regulation of thromboxane receptor trafficking through the prostacyclin receptor in vascular smooth muscle cells: role of receptor heterodimerization
Stephen J Wilson, Jennifer K Dowling, Lei Zhao, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
December 4, 2012
Endothelial 12(S)-HETE vasorelaxation is mediated by thromboxane receptor inhibition in mouse mesenteric arteries
Lawan Siangjong, Kathryn M Gauthier, Sandra L Pfister, et al.
Molecular Pharmacology
|
July 19, 2003
Prostacylin receptor activation inhibits proliferation of aortic smooth muscle cells by regulating cAMP response element-binding protein- and pocket protein-dependent cyclin a gene expression
Devashish Kothapalli, Sheryl A Stewart, Emer M Smyth, et al.
Breast Cancer Research : BCR
|
September 6, 2013
Mammary carcinoma cell derived cyclooxygenase 2 suppresses tumor immune surveillance by enhancing intratumoral immune checkpoint activity
Nune Markosyan, Edward P Chen, Rebecca A Evans, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
June 5, 2010
Dominant negative actions of human prostacyclin receptor variant through dimerization: implications for cardiovascular disease
Salam Ibrahim, Mazell Tetruashvily, Alex J Frey, et al.
Journal of Lipid Research
|
January 20, 2009
Activation-dependent stabilization of the human thromboxane receptor: role of reactive oxygen species
Stephen J Wilson, Claire C Cavanagh, Allison M Lesher, et al.
Page
of 3